RNO-6

N/A

Report date: 2022/08/29 14:39:56
NME

Base Information

Drug NameRNO-6
Drug Alias NameRNO-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSun Yat-Sen UniversityChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen UniversityChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A